Shara Ticku is the CEO and Co-Founder of C16 Biosciences, an award-winning, climate-tech startup using innovative processes found in nature to brew sustainable alternatives to palm oil as well as other fats and oils. C16’s proprietary technology platform uses biomanufacturing to create next-generation ingredients and materials that successfully address global ESG challenges including climate change, food security, the environmental and safety impacts of natural resource extraction, and more. Shara and her co-founders, David Heller and Harry McNamara, established C16 in 2018. Before co-founding C16, Shara worked at Goldman Sachs, the Clinton Health Access Initiative (CHAI), and held positions with Progyny and the United Nations Special Envoy for Health and Malaria. Shara holds an MBA from Harvard Business School and a BA/BBA from the University of Texas. Shara has been recognized as an Unreasonable Fellow, a UBS Global Visionary, and currently serves as an Entrepreneur in Residence at Harvard Business School.